Drugs / Interferon α-5
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01121731 | May 2010 → Oct 2012 | chronic hepatitis C virus infection | Digna Biotech S.L. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Interferon α-5 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01121731 ↗ |